News
13h
GlobalData on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesi | ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
The Independent on MSN2h
Weight-loss jabs could reduce asthma symptoms in obese people, study saysResearchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...
Explore more
WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...
8h
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking OzempicMany people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS ...
There are several strategies to help you control your portion sizes and avoid mindless snacking. We’ve all been there. You ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results